CRMP-5 activators belong to a distinctive class of chemical compounds designed to modulate the activity of collapsin response mediator protein 5 (CRMP-5). CRMP-5, also known as DPYSL5 (dihydropyrimidinase-like 5), is a multifunctional phosphoprotein that plays a pivotal role in neuronal development, axonal guidance, and neuroplasticity. The activators targeting CRMP-5 are specifically formulated to enhance the protein's functional capabilities by influencing its phosphorylation status or conformational changes. This class of compounds typically interacts with key residues on the CRMP-5 molecule, affecting its interaction with other cellular components and pathways.
The molecular mechanisms underlying CRMP-5 activation involve intricate signaling cascades within neurons. By modulating CRMP-5, these activators may impact various cellular processes, including cytoskeletal dynamics, neurite outgrowth, and synaptic plasticity. This class of chemicals represents a nuanced approach to manipulating intracellular events associated with neuronal function and development. Research into CRMP-5 activators is advancing our understanding of the intricate molecular pathways that govern neurobiology, offering potential insights into the fundamental processes that shape the nervous system.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
As a secondary messenger, cAMP can activate protein kinase A (PKA), which could potentially stimulate the activity of CRMP-5 via phosphorylation changes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. By inhibiting ROCK, it could potentially stimulate the activity of CRMP-5, as ROCK is known to phosphorylate and thus control the activity of CRMP-2, a protein closely related to CRMP-5. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is an inhibitor of GSK3β, a kinase that phosphorylates and inactivates CRMP-2. By inhibiting GSK3β, lithium might potentially stimulate the activity of CRMP-5. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
NMDA is an agonist for the NMDA receptor. By stimulating NMDA receptor activity, it could potentially enhance the activity of CRMP-5, given the protein's role in neuronal differentiation and growth. | ||||||